GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nagaileben Co 7447.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,705

+1.55%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥17.21bn

FY2017FY2026

Net income

¥2.65bn

FY2017FY2026

Free cash flow

¥3.31bn

FY2017FY2026

Shareholders' equity

¥39.06bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥17.21bn¥16.98bn¥16.41bn¥17.18bn¥17.75bn¥17.56bn¥17.07bn¥16.79bn¥17.14bn¥17.02bn
Gross profit¥6.73bn¥6.57bn¥6.90bn¥7.41bn¥7.72bn¥7.87bn¥7.61bn¥7.64bn¥7.85bn¥7.87bn
Research and development—¥190.9m¥193.2m¥199.9m¥187.2m¥188.4m¥165.2m¥181.2m¥175.2m¥174.9m
Operating income¥3.63bn¥3.58bn¥4.00bn¥4.60bn¥5.03bn¥5.21bn¥4.94bn¥4.92bn¥5.26bn¥5.24bn
Net income¥2.65bn¥2.57bn¥2.82bn¥3.23bn¥3.78bn¥3.65bn¥3.47bn¥3.45bn¥3.68bn¥3.67bn
Diluted earnings per share89.2784.4889.95100.90117.12110.99105.73103.85110.57110.49

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥42.19bn¥44.77bn¥46.76bn¥47.41bn¥47.40bn¥46.63bn¥45.04bn¥44.41bn¥42.80bn¥41.05bn
Cash and short-term investments¥22.40bn¥24.25bn¥26.35bn¥27.16bn¥28.56bn¥27.88bn¥25.65bn¥25.16bn¥23.93bn¥22.76bn
Total liabilities¥3.14bn¥3.45bn¥4.06bn¥4.19bn¥5.14bn¥4.60bn¥4.92bn¥4.69bn¥4.45bn¥4.51bn
Shareholders' equity¥39.06bn¥41.32bn¥42.70bn¥43.21bn¥42.26bn¥42.03bn¥40.12bn¥39.72bn¥38.35bn¥36.55bn
Shares outstanding30m30m31m32m32m33m33m33m33m33m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥3.53bn¥2.18bn¥2.29bn¥1.81bn¥3.44bn¥4.45bn¥3.63bn¥3.43bn¥4.01bn¥3.98bn
Capital spending−¥222.1m−¥291.5m−¥142.5m−¥284.4m−¥115.6m−¥248.8m−¥177.7m−¥231.5m−¥878.9m−¥103.0m
Free cash flow¥3.31bn¥1.89bn¥2.14bn¥1.53bn¥3.33bn¥4.20bn¥3.46bn¥3.20bn¥3.13bn¥3.88bn
Dividends paid−¥3.05bn−¥1.89bn−¥1.93bn−¥1.94bn−¥1.97bn−¥1.97bn−¥1.99bn−¥1.99bn−¥1.99bn−¥1.66bn

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Revenue¥3.94bn¥5.41bn¥4.94bn¥2.92bn¥3.62bn¥5.52bn¥4.63bn¥3.21bn
Gross profit¥1.58bn¥2.21bn¥1.96bn¥1.14bn¥1.42bn¥2.17bn¥1.84bn¥1.28bn
Operating income¥933.1m¥1.43bn¥968.6m¥412.5m¥667.6m¥1.42bn¥919.8m¥579.3m
Net income¥604.1m¥1.03bn¥696.9m¥317.5m¥507.0m¥1.00bn¥648.9m¥413.6m
Diluted earnings per share20.3534.7523.4710.4216.6432.9621.3013.18
Cash from operations——————−¥115.0m−¥115.0m
Capital spending——————−¥68.0m−¥68.0m
Free cash flow——————−¥183.0m−¥183.0m
Total assets¥42.19bn¥42.73bn¥41.47bn¥41.54bn¥44.77bn¥44.46bn¥43.89bn¥44.13bn
Cash and short-term investments¥22.40bn¥21.93bn¥19.62bn¥20.35bn¥24.25bn¥22.69bn¥23.06bn¥23.37bn
Shareholders' equity¥39.06bn¥39.42bn¥38.37bn¥38.34bn¥41.32bn¥40.75bn¥40.74bn¥40.67bn

Financial ratios

Data as of 17 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2016FY2014
Gross margin38.7%42.0%43.1%43.5%44.8%44.6%———
Operating margin21.1%24.4%26.8%28.4%29.7%28.9%———
Net margin15.2%17.2%18.8%21.3%20.8%20.4%———
Return on equity6.2%6.6%7.5%8.9%8.7%8.7%———
Return on assets5.7%6.0%6.8%8.0%7.8%7.7%———
Free cash flow yield4.9%4.7%4.0%6.7%8.6%7.0%———
Revenue growth3.5%-4.5%-3.2%1.0%2.9%1.7%———
Earnings growth-8.8%-12.5%-14.6%3.6%5.0%0.8%———
Current ratio14.44x12.32x12.10x9.61x11.18x9.68x———
Debt to equity———0.00x0.00x0.00x———
Equity ratio92.3%91.3%91.2%89.1%90.1%89.1%———
Interest coverage———2095.66x88.26x54.18x72.66x235757.90x68380.74x
R&D as a share of sales1.1%1.2%1.2%1.1%1.1%1.0%———
Buybacks as a share of market value2.9%1.9%0.9%1.8%-0.0%1.0%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.0%-0.4%0.4%
Operating income-7.7%-7.0%-3.1%
Net income-6.3%-6.2%-2.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin38.9%40.7%41.9%43.5%
Operating margin21.1%23.3%25.3%27.4%
Net margin15.3%16.6%18.1%19.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings19.521.324.523.617.020.427.923.121.425.6
Price to sales3.03.24.24.43.64.25.74.74.65.5

Dividends and splits

Per share, in the currency the company pays

Paid for 34 years. Last went ex-dividend on 28 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year70.00120.0060.0060.0060.0060.0060.0060.00
  • 2-for-1 split · 29 Aug 2011
  • 2-for-1 split · 24 Feb 2004
  • 1.1-for-1 split · 27 Aug 1996

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.